• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » AtriCure touts first case with new FDA-cleared AtriClip Flex-Mini

AtriCure touts first case with new FDA-cleared AtriClip Flex-Mini

August 27, 2024 By Sean Whooley

AtriCure AtriClip Flex Mini (1)
The AtriClip Flex-Mini. [Image from the AtriCure website]
AtriCure (Nasdaq: ATRC) today announced the first patient treated with its AtriClip Flex-Mini device.

The AtriClip Flex-Mini device recently received FDA 510(k) clearance. Mason, Ohio-based AtriCure says it’s the smallest-profile left atrial appendage (LAA) device on the market. It builds upon the company’s AtriClip platform with ease of use and design simplicity for enhanced access and increased visibility.

AtriClip Flex-Mini features a fully enclosed design with parallel beams for continuous closing force to ensure optimal pressure on atrial tissue. Its low-profile design enhances visibility without compromising stability, according to a news release. This provides physicians with what AtriCure calls “unprecedented control” during procedures.

Additionally, the device has an ergonomic handle design to enable single-handed placement. That further simplifies the application process for AtriClip Flex-Mini.

Dr. Ibrahim S. Sultan serves as a professor and chief of the division of cardiac surgery at University of Pittsburgh Medical Center. Sultan called AtriClip Flex-Mini “a significant step forward” in ensuring the best possible treatment for patients.

“The AtriClip FLEX-Mini is an unparalleled product that reinforces our position as the market leader in surgical LAA management,” said Michael Carrel, President and Chief Executive Officer at AtriCure. “With nearly 600,000 AtriClip devices sold globally, we are having a significant impact on patients’ lives. Continuing to innovate and enhance the unique features of our AtriClip platform will support even greater growth in this market.”

As the LAA space heats up, AtriCure continues to add to its portfolio. The company said late last year that it expected a launch for AtriClip Flex-Mini in the second half of 2024, inspiring optimism among analysts.

Elsewhere in the LAA market, Medtronic launched the Penditure left atrial appendage (LAA) exclusion device in November 2023, adding another system to the competitive space. Abbott and Boston Scientific also offer LAA devices, while Johnson & Johnson MedTech made its own play in the market last year, too. AtriCure’s management team said last year that it welcomes the competition.

Filed Under: Cardiac Implants, Cardiovascular, Featured, Structural Heart, Surgical Tagged With: atricure, AtriCure Inc.

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy